Comparison of oxaliplatin- and cisplatin-induced painful peripheral neuropathy in the rat
- PMID: 19231296
- PMCID: PMC2741410
- DOI: 10.1016/j.jpain.2008.12.003
Comparison of oxaliplatin- and cisplatin-induced painful peripheral neuropathy in the rat
Abstract
Although platinum-based cancer chemotherapies produce painful peripheral neuropathy as dose-limiting side effects, there are important differences in the pain syndromes produced by members of this class of drugs. In the rat, cisplatin-induced hyperalgesia has latency to onset of 24 to 48 hours, is maximal by 72 to 96 hours, and is attenuated by inhibitors of caspase signaling but not by inhibitors of the mitochondrial electron transport chain (mETC) and antioxidants. In contrast, oxaliplatin-induced mechanical hyperalgesia is already present by 5 minutes and peaks by 20 minutes. Whereas oxaliplatin hyperalgesia persists for weeks, starting around day 10 to 15, its severity decreases to a lower 2nd plateau level. The rapid-onset 1st plateau in oxaliplatin-induced hyperalgesia was characterized by prominent cold allodynia and in contrast to cisplatin was attenuated by inhibitors of the mETC and antioxidants but not inhibitors of caspase signaling. However, tested later during the 2nd plateau, it was characterized by less intense hyperalgesia and no cold allodynia and was attenuated by inhibitors of caspase signaling as well as by inhibitors of the mETC and by antioxidants.
Perspective: The findings of this study distinguish between the neuropathic pain syndromes produced by members of a single chemical class of anticancer drugs and suggest that the underlying mechanisms of various forms of peripheral neuropathy may be different. Further, it defines the need for selective therapy for different types of neuropathy.
Figures



Similar articles
-
Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy.J Pain. 2008 May;9(5):463-72. doi: 10.1016/j.jpain.2008.01.335. Epub 2008 Mar 24. J Pain. 2008. PMID: 18359667
-
Behavioral and immunohistological assessment of painful neuropathy induced by a single oxaliplatin injection in the rat.Toxicology. 2007 May 20;234(3):176-84. doi: 10.1016/j.tox.2007.02.013. Epub 2007 Mar 1. Toxicology. 2007. PMID: 17418472
-
Oxaliplatin-induced neuropathy in the rat: involvement of oxalate in cold hyperalgesia but not mechanical allodynia.Pain. 2009 Dec 15;147(1-3):165-74. doi: 10.1016/j.pain.2009.09.003. Epub 2009 Sep 25. Pain. 2009. PMID: 19782472
-
[Role of Transient Receptor Potential Channels in Paclitaxel- and Oxaliplatin-induced Peripheral Neuropathy].Yakugaku Zasshi. 2016;136(2):287-96. doi: 10.1248/yakushi.15-00214. Yakugaku Zasshi. 2016. PMID: 26831807 Review. Japanese.
-
Chemotherapy-induced painful neuropathy: pain-like behaviours in rodent models and their response to commonly used analgesics.Curr Opin Support Palliat Care. 2016 Jun;10(2):119-128. doi: 10.1097/SPC.0000000000000204. Curr Opin Support Palliat Care. 2016. PMID: 27054288 Free PMC article. Review.
Cited by
-
Contribution of Piezo2 to endothelium-dependent pain.Mol Pain. 2015 Oct 24;11:65. doi: 10.1186/s12990-015-0068-4. Mol Pain. 2015. PMID: 26497944 Free PMC article.
-
Role of Drp1, a key mitochondrial fission protein, in neuropathic pain.J Neurosci. 2011 Aug 3;31(31):11404-10. doi: 10.1523/JNEUROSCI.2223-11.2011. J Neurosci. 2011. PMID: 21813700 Free PMC article.
-
Significance of Kampo, traditional Japanese medicine, in supportive care of cancer patients.Evid Based Complement Alternat Med. 2013;2013:746486. doi: 10.1155/2013/746486. Epub 2013 Jun 19. Evid Based Complement Alternat Med. 2013. PMID: 23861712 Free PMC article.
-
Mechanisms involved in the development of chemotherapy-induced neuropathy.Pain Manag. 2015;5(4):285-96. doi: 10.2217/pmt.15.19. Epub 2015 Jun 19. Pain Manag. 2015. PMID: 26087973 Free PMC article. Review.
-
Exploration for Blood Biomarkers of Human Long Non-coding RNAs Predicting Oxaliplatin-Induced Chronic Neuropathy Through iPS Cell-Derived Sensory Neuron Analysis.Mol Neurobiol. 2024 Sep;61(9):7168-7180. doi: 10.1007/s12035-024-04017-7. Epub 2024 Feb 19. Mol Neurobiol. 2024. PMID: 38374315
References
-
- Abrey LE, Correa DD. Treatment-related neurotoxicity. Hematol Oncol Clin North Am. 2005;19:729–738. viii. - PubMed
-
- Adelsberger H, Quasthoff S, Grosskreutz J, Lepier A, Eckel F, Lersch C. The chemotherapeutic oxaliplatin alters voltage-gated Na(+) channel kinetics on rat sensory neurons. Eur J Pharmacol. 2000;406:25–32. - PubMed
-
- Aley KO, Levine JD. Different peripheral mechanisms mediate enhanced nociception in metabolic/toxic and traumatic painful peripheral neuropathies in the rat. Neuroscience. 2002;111:389–397. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical